INO — INOVIO PHARMACEUTICALS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1055726 ·
Last close
$1.09
Market Cap
$112.70M
52W High
$2.72
52W Low
$0.56
ADV30
2,880,966
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 0 | — | -21,949,993 | -19,682,798 | 49,777,142 | 26,271,650 | 43,709,260 |
| Dec 2025 | 0 | — | -17,476,601 | 3,764,880 | 74,310,035 | 44,273,319 | 50,213,759 |
| Sep 2025 | 0 | — | -21,210,455 | -45,496,672 | 69,385,656 | 36,567,420 | 77,105,633 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-83,346,719
Investing CF
$16,726,967
Financing CF
$52,975,955
CapEx
$-285,698
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.27
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,834,847,961
Inventory
—
Receivables
$450
ST Investments
$11,409,607
EBIT TTM
$-87,201,197
Pretax Income TTM
$-84,934,002
Interest Exp TTM
$0
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
$-77,932,296
Free Cash Flow
$-33,856,480
Enterprise Value
$100,574,872
Total Cash
$36,674,016
Total Debt
$8,001,989
Shares Out
103,397,518
Trailing EPS
$-1.03
Book Value
$0.05
ROE
-409.9%
ROA
-84.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 65,343 | -86,822,104 | -84,945,901 | 74,310,035 | 50,213,759 | 24,096,276 | -88,629,430 |
| Dec 2024 | 217,756 | -112,398,922 | -107,254,126 | 113,197,206 | 44,693,411 | 68,503,795 | -104,076,553 |
| Dec 2023 | 832,010 | -133,426,657 | -135,117,352 | 170,951,423 | 53,602,294 | 117,349,129 | -124,365,551 |
| Dec 2022 | 10,262,268 | -267,573,520 | -279,818,065 | 348,533,302 | 126,170,546 | 222,362,756 | -216,215,421 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-84,934,002
OpCashFlow TTM
—
Assets (Latest)
$49,777,142
Forward EPS
$-0.44
Max Pain — expiry 2026-10-16
max pain strike: $1.00 · spot: $1.15 · call oi: 10,469 · put oi: 135
Expected Move to 2026-10-16:
±$0.15
(13.04%) —
implied range
$1.00 –
$1.30
· ATM straddle on $1.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GNLX | GENELUX Corp | $113.11M | $2.50 | — |
| UNCY | Unicycive Therapeutics, Inc. | $111.49M | $4.07 | — |
| QUCY | Quantum Cyber N.V. | $116.85M | $1.39 | — |
| COYA | Coya Therapeutics, Inc. | $117.05M | $4.99 | — |
| FHTX | Foghorn Therapeutics Inc. | $118.18M | $1.99 | — |
News headlines (Yahoo Finance, 1h cache)
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms
2026-09-11 13:02 · Yahoo
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP
2026-09-10 11:02 · Yahoo
INOVIO to Participate in Upcoming Investor Conferences
2026-09-01 20:05 · Yahoo
Inovio Pharmaceuticals Inc (INO) (Q2 2026) Earnings Call Highlights: INO-3107 on Track for ...
2026-08-13 05:03 · Yahoo
Inovio Pharmaceuticals Shareholders Back Board as INO-3107 FDA Review Advances
2026-05-25 18:02 · Yahoo
INOVIO to Report Second Quarter Financial Results on August 12, 2026
2026-08-04 20:05 · Yahoo
INOVIO to Participate in Upcoming Scientific and Investor Conferences
2026-05-28 12:05 · Yahoo
INO Stock Edges Up After Hours As Partner Reports Success In Cervical Dysplasia Trial
2026-05-21 21:37 · Yahoo
FDA Backs PFE's Tukysa Combo in Front-Line Maintenance Breast Cancer
2026-10-08 14:45 · Yahoo
PGEN Stock Up More Than 50% in 3 Months: Here's What You Should Know
2026-10-05 14:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.